Minimal Impact on Patients’ Health Utilities Associated With Adverse Events in Metastatic Merkel Cell Carcinoma Patients on Treatment With Avelumab

Value in Health - United Kingdom
doi 10.1016/j.jval.2017.08.281
Full Text
Abstract

Available in full text

Date
Authors
Publisher

Elsevier BV

Related search

Efficacy and Safety of First-Line Avelumab Treatment in Patients With Stage IV Metastatic Merkel Cell Carcinoma

JAMA Oncology
Cancer ResearchOncology
2018English

PD-L1 Inhibition With Avelumab for Metastatic Merkel Cell Carcinoma

Expert Review of Clinical Pharmacology
MedicineToxicologyPharmaceuticsPharmacology
2018English

Practical Management of Adverse Events Associated With Cabozantinib Treatment in Patients With Renal-Cell Carcinoma

OncoTargets and Therapy
OncologyPharmacology
2017English

Avelumab in the Treatment of Patients With Merkel Cell Carcinoma: Initial Results of Early Access Program in Russia

Malignant tumours
2019English

Updated Efficacy of Avelumab in Patients With Previously Treated Metastatic Merkel Cell Carcinoma After ≥1 Year of Follow-Up: JAVELIN Merkel 200, a Phase 2 Clinical Trial

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2018English

Adverse Events Associated With Bevacizumab and Chemotherapy in Older Patients With Metastatic Colorectal Cancer

Clinical Colorectal Cancer
OncologyGastroenterology
2013English

Correction To: Serious Adverse Events and Fatal Adverse Events Associated With Nivolumab Treatment in Cancer Patients

Journal for ImmunoTherapy of Cancer
OncologyMolecular MedicinePharmacologyCancer ResearchAllergyImmunology
2019English

Pcn341 - Estimation of Utilities on Skeletal-Related Events (Sre) in Patients With Bone Metastatic Cancer in Korea

Value in Health
MedicineHealth PolicyPublic HealthOccupational HealthEnvironmental
2018English

Diffuse Lichen Planus-Like Keratoses and Clinical Pseudo-Progression Associated With Avelumab Treatment for Merkel Cell Carcinoma, a Case Report

BMC Cancer
Cancer ResearchOncologyGenetics
2019English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy